James Michael Koch, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20776 Brantley Rd, Shaker Heights, OH 44122 Phone: 216-296-2108 |
Dr. Joseph Askenazi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 23951 Hermitage Rd, Shaker Heights, OH 44122 Phone: 216-406-1479 |
News Archive
In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment.
Cancer immunology is based upon boosting the body's own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells - one of the immune system's primary weapons - to treat three different types of blood cancer that often defy existing therapies.
Researchers in the UK, United States, and Sweden have presented new findings that could help identify individuals at risk of "long COVID" – a protracted course of coronavirus disease 2019 (COVID-19) symptoms last for more than 28 days.
A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial. The newly patented system matches the registered patient's own molecular profile - warehoused in a database of thousands of patient-donated biological tissue or tumor samples - to the molecular design of the drug aimed at targeting their disease at the molecular level, and does it quickly.
New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.
› Verified 5 days ago